107 related articles for article (PubMed ID: 9929509)
1. In vivo metabolism of the antitumor imidazoacridinone C1311 in the mouse and in vitro comparison with humans.
Calabrese CR; Loadman PM; Lim LS; Bibby MC; Double JA; Brown JE; Lamb JH
Drug Metab Dispos; 1999 Feb; 27(2):240-5. PubMed ID: 9929509
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics and tissue distribution of the imidazoacridinone C1311 in tumour-bearing mice.
Calabrese CR; Bibby MC; Double JA; Loadman PM
Cancer Chemother Pharmacol; 1998; 42(5):379-85. PubMed ID: 9771952
[TBL] [Abstract][Full Text] [Related]
3. NTP technical report on the toxicity and metabolism studies of chloral hydrate (CAS No. 302-17-0). Administered by gavage to F344/N rats and B6C3F1 mice.
Beland FA
Toxic Rep Ser; 1999 Aug; (59):1-66, A1-E7. PubMed ID: 11803702
[TBL] [Abstract][Full Text] [Related]
4. Metabolic transformations of antitumor imidazoacridinone, C-1311, with microsomal fractions of rat and human liver.
Wiśniewska A; Chrapkowska A; Kot-Wasik A; Konopa J; Mazerska Z
Acta Biochim Pol; 2007; 54(4):831-8. PubMed ID: 18084652
[TBL] [Abstract][Full Text] [Related]
5. Cellular uptake, cytotoxicity and DNA-binding studies of the novel imidazoacridinone antineoplastic agent C1311.
Burger AM; Jenkins TC; Double JA; Bibby MC
Br J Cancer; 1999 Sep; 81(2):367-75. PubMed ID: 10496367
[TBL] [Abstract][Full Text] [Related]
6. Metabolism of the experimental antitumor agent acridine carboxamide in the mouse.
Robertson IG; Palmer BD; Paxton JW; Bland TJ
Drug Metab Dispos; 1993; 21(3):530-6. PubMed ID: 8100511
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetic studies in mice of two new thioxanthenones (183577 and 232759) that showed preferential solid tumor activity.
Foster BJ; Wiegand RA; Pugh S; LoRusso PM; Rake J; Corbett TH
Clin Cancer Res; 1997 Nov; 3(11):2047-53. PubMed ID: 9815596
[TBL] [Abstract][Full Text] [Related]
8. HPLC-NMR with severe column overloading: fast-track metabolite identification in urine and bile samples from rat and dog treated with [14C]-ZD6126.
Lenz EM; D'Souza RA; Jordan AC; King CD; Smith SM; Phillips PJ; McCormick AD; Roberts DW
J Pharm Biomed Anal; 2007 Feb; 43(3):1065-77. PubMed ID: 17030109
[TBL] [Abstract][Full Text] [Related]
9. Characterization of the major metabolites of flavone acetic acid and comparison of their disposition in humans and mice.
Cummings J; Double JA; Bibby MC; Farmer P; Evans S; Kerr DJ; Kaye SB; Smyth JF
Cancer Res; 1989 Jul; 49(13):3587-93. PubMed ID: 2731178
[TBL] [Abstract][Full Text] [Related]
10. Analysis of di-n-butylphthalate biotransformation in cattle by liquid chromatography/ion trap mass spectrometry/mass spectrometry.
Coldham NG; Dave M; Sauer MJ
J Mass Spectrom; 1998 Sep; 33(9):803-10. PubMed ID: 9768498
[TBL] [Abstract][Full Text] [Related]
11. Compatibility and stability of the novel anti-cancer agent C1311 in infusion devices and its in vitro biocompatibility.
den Brok MW; Nuijen B; Harms R; Buluran JN; Harvey MD; Grieshaber CK; Beijnen JH
J Oncol Pharm Pract; 2005 Mar; 11(1):13-9. PubMed ID: 16460599
[TBL] [Abstract][Full Text] [Related]
12. Analysis of the imidazoacridinone C1311 by high-performance liquid chromatography.
Calabrese CR; Loadman PM
J Chromatogr B Biomed Sci Appl; 1997 Mar; 690(1-2):275-81. PubMed ID: 9106053
[TBL] [Abstract][Full Text] [Related]
13. Metabolism of olaquindox in rat liver microsomes: structural elucidation of metabolites by high-performance liquid chromatography combined with ion trap/time-of-flight mass spectrometry.
Liu Z; Huang L; Dai M; Chen D; Wang Y; Tao Y; Yuan Z
Rapid Commun Mass Spectrom; 2008 Apr; 22(7):1009-16. PubMed ID: 18320546
[TBL] [Abstract][Full Text] [Related]
14. In vivo metabolism of a new anticancer agent, 6-N-formylamino-12, 13-dihydro-1,11-dihydroxy-13-(beta-D-glucopyranosil)5H-indolo [2,3-a]pyrrolo [3,4-c]carbazole-5,7(6H)-dione (NB-506) in rats and dogs: pharmacokinetics, isolation, identification, and quantification of metabolites.
Takenaga N; Ishii M; Nakajima S; Hasegawa T; Iwasa R; Ishizaki H; Kamei T
Drug Metab Dispos; 1999 Feb; 27(2):205-12. PubMed ID: 9929504
[TBL] [Abstract][Full Text] [Related]
15. Biotransformation of a novel antimitotic agent, I-387, by mouse, rat, dog, monkey, and human liver microsomes and in vivo pharmacokinetics in mice.
Ahn S; Kearbey JD; Li CM; Duke CB; Miller DD; Dalton JT
Drug Metab Dispos; 2011 Apr; 39(4):636-43. PubMed ID: 21233217
[TBL] [Abstract][Full Text] [Related]
16. NTP technical report on the toxicity studies of Dibutyl Phthalate (CAS No. 84-74-2) Administered in Feed to F344/N Rats and B6C3F1 Mice.
Marsman D
Toxic Rep Ser; 1995 Apr; 30():1-G5. PubMed ID: 12209194
[TBL] [Abstract][Full Text] [Related]
17. Preclinical pharmacology of 2-methoxyantimycin A compounds as novel antitumor agents.
Wang H; Li M; Rhie JK; Hockenbery DM; Covey JM; Zhang R; Hill DL
Cancer Chemother Pharmacol; 2005 Sep; 56(3):291-8. PubMed ID: 15883820
[TBL] [Abstract][Full Text] [Related]
18. Metabolism of the A(1)1 adenosine receptor positron emission tomography ligand [18F]8-cyclopentyl-3-(3-fluoropropyl)-1-propylxanthine ([18F]CPFPX) in rodents and humans.
Bier D; Holschbach MH; Wutz W; Olsson RA; Coenen HH
Drug Metab Dispos; 2006 Apr; 34(4):570-6. PubMed ID: 16415116
[TBL] [Abstract][Full Text] [Related]
19. Biotransformation of 6-methoxy-3-(3',4',5'-trimethoxy-benzoyl)-1H-indole (BPR0L075), a novel antimicrotubule agent, by mouse, rat, dog, and human liver microsomes.
Yao HT; Wu YS; Chang YW; Hsieh HP; Chen WC; Lan SJ; Chen CT; Chao YS; Chang L; Sun HY; Yeh TK
Drug Metab Dispos; 2007 Jul; 35(7):1042-9. PubMed ID: 17403915
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of the cassette dosing approach for assessing the pharmacokinetics of geldanamycin analogues in mice.
Smith NF; Hayes A; Nutley BP; Raynaud FI; Workman P
Cancer Chemother Pharmacol; 2004 Dec; 54(6):475-86. PubMed ID: 15526201
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
